Canadian Cannabis Stocks Drop Over 9% in October

After breaking a three-month losing streak with a 1% gain in June and then retreating almost 27% in Q3, the Canadian Cannabis LP Index  extended its losing streak to four months as it fell sharply again in October, declining 9.5% to 238.48:

The index, which fell 30.1% in 2020 to end at 275.16, is up 2.0% over the past year but down 13.3% year-to-date in 2021:

It remains substantially below the all-time closing high of 1314.33 in September 2018, just ahead of Canadian adult-use legalization. In March 2020, it posted a new 52-week closing low of 196.10, a level not seen since late 2016, and it closed 21.6% above that level at the end of October:

The Canadian Cannabis LP Index, which is rebalanced monthly, included 39 qualifying publicly traded licensed producers that traded in Canada at the end of September, with equal weighting for each stock. Each of the members was also included in a sub-index, with 4 in the Canadian Cannabis LP Tier 1 Index, 15 in the Canadian Cannabis LP Tier 2 Index and 20 in the Canadian Cannabis LP Tier 3 Index during the month. At the end of June 2020, we revised the rules for inclusion, requiring companies to have a price of at least C$0.20 unless they are generating at least C$2.5 million quarterly from their cannabis production operation. Previously, we required revenue in excess of C$1 million for stocks trading below C$0.20. There are currently more than a dozen publicly traded LPs that fail to qualify.

Tier 1

Tier 1, which included the LPs that are generating cannabis-related sales of at least C$25 million per quarter, fell 9.9% to 423.95 in October. Tier 1, which dropped 23.9% in 2020 when it ended at 488.96, has declined 13.3% in 2021. We have increased the minimum revenue required to be included over time. At the beginning of 2021, we raised it from C$20 million. During 2019 and the first half of 2020, companies needed to generate revenue in excess of C$10 million for inclusion. In 2018, we used C$4 million as the hurdle.

This group included Aurora Cannabis (TSX: ACB) (NASDAQ: ACB), Canopy Growth (TSX: WEED) (NASDAQ: CGC), Tilray (TSX: TLRY) (NASDAQ: TLRY) and Village Farms (TSX: VFF) (NASDAQ: VFF).

Among these largest LPs by revenue, Aurora Cannabis was the best performer at -6% for the second consecutive month, while Canopy Growth and Tilray both fell-11%.

Tier 2

Tier 2, which included the LPs that generate cannabis-related quarterly sales between C$5 million and C$25 million, fell 10.4% to 356.05. In 2020, it lost 35.9% in 2020, closing at 365.19, and it is down 2.5% in 2021. Prior to July 2020, companies needed revenue in excess of C$2.5 million to be included in this tier.

This group included Aleafia Health (TSX: AH) (OTC: ALEAF), Auxly (TSX: XLY) (OTC: CBWTF), Cannara Biotech (TSXV: LOVE) (OTC: LOVFF), Cronos Group (TSX: CRON) (NASDAQ: CRON), Decibel Cannabis (TSXV: DB) (OTC: DBCCF), Delta 9 (TSX: DN) (OTC: DLTNF), Entourage Health (TSXV: ENTG) (OTC: ETRGF), HEXO Corp (TSX: HEXO) (NASDAQ: HEXO), Indiva (TSXV: NDVA) (OTC: NDVAF) MediPharm Labs (TSX: LABS) (OTC: MEDIF), Organigram (TSX: OGI) (NASDAQ: OGI), TerrAscend (CSE: TER) (OTC: TRSSF), The Green Organic Dutchman (CSE: TGOD) (OTC: TGODF), Valens Company (TSX: VLNS) (OTC: VLNCF) and VIVO Cannabis (TSX: VIVO) (OTC: VVCIF).

Two stocks dropped more than 20%, including Hexo, -22%, and Valens, -20%. VIVO Cannabis and Decibel were the only Tier 2 names to post gains.

Tier 3

Tier 3, which included the 20 qualifying LPs that generate cannabis-related quarterly sales less than C$5 million, fell 8.7% as it closed at 53.12. It ended at 66.59 in 2020, declining 31.2%, and is down 20.2% in 2021. Nextleaf Solutions (CSE: OILS) (OTC: OILFF) was the strongest Tier 3 name for the second consecutive month. The worst performer was Bevcanna (CSE: BEV) (OTC: BVNNF), falling 26%.

The returns for the overall sector varied greatly, with 3 names posting double-digit gains and 7 declining by more than 20%. The entire group posted a median return of -10.9%:

For November, the overall index will have 39 constituents, with the removal of Eve & Co (TSXV: EVE) (OTC: EEVVFF) and the addition of Greenway Greenhouse Cannabis (CSE: GWAY), which joins in Tier 3.

In the next monthly review, we will summarize the performance for November and discuss any additions or deletions. Be sure to bookmark the pages to stay current on LP stock price movements within the day or from day-to-day.


Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter